Theravance News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.02.14	Anoro Gets Positive CHMP Opinion For COPD Treatment - Quick Facts (RTTNews)
06.02.14	Theravance Q4 Loss Widens - Quick Facts (RTTNews)
19.12.13	FDA Oks GSK-Theravance's Anoro Ellipta To Treat COPD (RTTNews)
06.12.13	GSK, Theravance Report Positive Results For FF/VI In Late Stage Asthma Study (RTTNews)
06.12.13	GSK, Theravance Report Positive Results From Phase III Study For FF/VI In Asthma (RTTNews)
30.10.13	GSK Says BREO ELLIPTA Available In U.S. For Treatment Of COPD (RTTNews)
22.10.13	Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda (PR Newswire)
07.10.13	Regulatory Approvals, Public Offerings and Clinical Trial Results - Research Report on Theravance, Synageva, Nektar, Clovis Oncology, and ImmunoGen (PR Newswire)
01.10.13	Technical Briefing: Celsion Corp., Theravance Inc., Alkermes PLC, and Hospira Inc. (PR Newswire)
25.09.13	Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta (PR Newswire)
20.09.13	GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma Treatment (RTTNews)
11.09.13	Acquisitions, Regulatory Filings, New Community Resource Centers and Successful Clinical Trials- Research Report on Baxter, Endo, HCA, Elan, and Theravance (PR Newswire)
11.09.13	FOLD Cuts A Deal, SNTA On Watch, NanoString Makes Mega Leap, GALT Vaults (RTTNews)
11.09.13	FDA Panel Votes In Favor Of Glaxo-Theravance's Lung Drug (RTTNews)
10.09.13	Pre-market Movers For Sept 10 (CAG, CROX, FOLD, FIVE, NBIX, CCXI, URBN, THRX) (RTTNews)
10.09.13	FDA Advisory Committee To Discuss ANORO ELLIPTA; Theravance Stock Halted (RTTNews)
05.09.13	THRX Breathes Easy, POZN Pops, RNN Begins Anew, ARIA On The Move (RTTNews)
04.09.13	Theravance Announces Positive Results From Phase 2b Study Of COPD Drug TD-4208 (RTTNews)
03.09.13	Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA (PR Newswire)
27.08.13	Today's Technical View: Alkermes plc, Hospira Inc., Celsion Corp., and Theravance Inc. (PR Newswire)
12.08.13	Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer (PR Newswire)
02.08.13	Expanding R&D Programs, Clinical Trials, Drug Applications and Acquisitions, Advancing to Help Patients with Unmet Medical Needs - Research Report on Questcor, BioMarin, Vanda, Illumina and Theravance (PR Newswire)
22.07.13	Critical Alerts For Wells Fargo, SunEdison, Cardinal Health, NVidia, and Theravance Released By InvestorsObserver (PR Newswire)
22.07.13	Technical Study: Hospira, Alkermes, Theravance, and Celsion (PR Newswire)
12.07.13	GlaxoSmithKline, Theravance Provide Update On Current Japanese NDA (RTTNews)
02.04.12	Wall Street-Schluss: Zugewinne, Konjunkturdaten im Fokus (Aktiencheck)
02.04.12	Wall Street Update: Konjunkturdaten sorgen für freundlichen Mittagshandel (Aktiencheck)
02.04.12	Wall Street Eröffnung: Leicht im Minus, Akquisitionen im Blick (Aktiencheck)
02.04.12	GSK: Beteiligung an Theravance soll aufgestockt werden (Aktiencheck)
02.04.12	SMI nach Schlussrally im Plus -- Dow Jones schliesst im Plus -- Illumina sagt Roche ab -- Mövenpick: weniger Umsatz - mehr Gewinn -- Ölpreise legen deutlich zu -- Dax schliesst mit sattem Gewinn (finanzen.ch)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	30.49	3.29 %	K V
Part Grp Hldg	1’329.00	2.31 %	K V
Roche Hldg G	271.80	1.84 %	K V
Givaudan	3’932.00	1.29 %	K V
Novartis	91.96	1.10 %	K V
Geberit	504.00	-0.36 %	K V
Swiss Re	134.25	-0.41 %	K V
CieFinRichemont	139.95	-0.71 %	K V
Zurich Insur Gr	543.20	-0.73 %	K V
Kuehne+Nagel Int	202.30	-2.46 %	K V

Nachrichten zu Theravance Inc.

Aktien Top/Flop

Meistgelesene Nachrichten